Systemic Vasculitis Developed After Immune Checkpoint Inhibition

Arthritis Care and Research - United States
doi 10.1002/acr.23481
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Wiley

Related search

Immune Checkpoint Inhibition in Patients With Brain Metastases

Annals of Translational Medicine
Medicine
2016English

Inhibition of QPCTL Induces Myeloid Immune Checkpoint Blockade

Cancer Discovery
Oncology
2019English

Immune Checkpoint Inhibition in Head and Neck Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

Immune Checkpoint Inhibition: From Molecules to Clinical Application

Clinical and Experimental Immunology
AllergyImmunology
2020English

Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages

Cell
BiochemistryGeneticsMolecular Biology
2018English

Systemic Immunological Biomarkers of Clinical Responses in Immune Checkpoint Blockade Therapies

Lung Cancer Management
2018English

MPO Inhibition Prevents Immune Complex Vasculitis and Anti-Glomerular Basement Membrane Diseases

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2015English

Treatment-Related Adverse Events and Response Rate to Immune Checkpoint Inhibition

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Systemic Vasculitis During the Course of Systemic Sclerosis

Medicine
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy